Nuzenio

Reuters Cytokinetics

Reuters Cytokinetics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 4 latest news signals 4 publisher sources 100/100 entity strength

Latest news

BRIEF-Cytokinetics Q2 Basic EPS USD -1.5 - TradingViewTradingView · Thu, 06 Aug 2026 20:01:01 GMTRecon: FDA adcomm votes against Capricor’s DMD drug; Cytokinetics gets UK approval, NICE backing for heart drug - RAPSRAPS · Thu, 30 Jul 2026 19:25:00 GMTCytokinetics wins UK approval, NICE backing for heart disease drug - ReutersReuters · Thu, 30 Jul 2026 07:00:00 GMTCytokinetics EVP, Chief Commercial Officer Andrew Callos sells 14,000 common shares for $1.12 million - BitgetBitget · Thu, 30 Jul 2026 07:00:00 GMT

Timeline

Thu, 06 Aug 2026 20:01:01 GMTBRIEF-Cytokinetics Q2 Basic EPS USD -1.5 - TradingView
Thu, 30 Jul 2026 19:25:00 GMTRecon: FDA adcomm votes against Capricor’s DMD drug; Cytokinetics gets UK approval, NICE backing for heart drug - RAPS
Thu, 30 Jul 2026 07:00:00 GMTCytokinetics wins UK approval, NICE backing for heart disease drug - Reuters
Thu, 30 Jul 2026 07:00:00 GMTCytokinetics EVP, Chief Commercial Officer Andrew Callos sells 14,000 common shares for $1.12 million - Bitget

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Reuters Cytokinetics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.